FLACW
Income statement / Annual
Last year (2021), Frazier Lifesciences Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, Frazier Lifesciences Acquisition Corp.'s net income was $9.74 M.
See Frazier Lifesciences Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$1.37 M
|
$120,884.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.37 M
|
$120,884.00
|
| Other Expenses |
$0.00 |
$0.00 |
| Operating Expenses |
$1.37 M |
$120,884.00 |
| Cost And Expenses |
$1.37 M |
$120,884.00 |
| Interest Income |
$16,158.00 |
$0.00 |
| Interest Expense |
$16,158.00 |
$0.00 |
| Depreciation &
Amortization |
$5.56 M
|
$851.00
|
| EBITDA |
$4.19 M
|
-$126,807.00
|
| EBITDA Ratio |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
| Total Other
Income/Expenses Net |
$5.54 M
|
$851.00
|
| Income Before Tax |
$4.18 M |
-$126,807.00 |
| Income Before Tax Ratio
|
0
|
0
|
| Income Tax Expense |
-$5.56 M |
$0.00 |
| Net Income |
$9.74 M |
-$126,807.00 |
| Net Income Ratio |
0 |
0 |
| EPS |
0.55 |
-0.0071 |
| EPS Diluted |
0.55 |
-0.0071 |
| Weighted Average Shares
Out |
$17.75 M
|
$17.75 M
|
| Weighted Average Shares
Out Diluted |
$17.75 M
|
$17.75 M
|
| Link |
|
|
